CYCLODEXTRIN COMPLEXATION OF NSAIDS - PHYSICOCHEMICAL CHARACTERISTICS

被引:98
作者
LOFTSSON, T [1 ]
OLAFSDOTTIR, BJ [1 ]
FRIORIKSDOTTIR, H [1 ]
JONSDOTTIR, S [1 ]
机构
[1] UNIV ICELAND, INST SCI, REYKJAVIK, ICELAND
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYCLODEXTRIN; SOLUBILIZATION; STABILIZATION;
D O I
10.1016/0928-0987(93)90023-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interactions of a number of NSAIDs, i.e. acetylsalicylic acid, ibuprofen, methyl acetylsalicylate, methyl salicylate, naproxen and tenoxicam, with five cyclodextrin (CD) derivatives, i.e. beta-cyclodextrin (betaCD), 2-hydroxypropyl-beta-cyclodextrin with molar substitution of 0.6 or 0.9 (HPbetaCD MS 0.6 or 0.9), 2-hydroxypropyl-gamma-cyclodextrin (HPgammaCD MS 0.6) and mixture of maltosyl/dimaltosyl-beta-cyclodextrin (M/DMbetaCD), was investigated. All the NSAIDs tested formed inclusion complexes with the CDs but addition of ethanol or propylene glycol to the aqueous CD solutions reduced their degree of complexation. Also, ionization of the NSAIDs normally reduced the degree of complexation. However, CD complexation of ionized drug molecules can result in much larger total solubilization, i.e. solubilization of a drug both due to CD complexation and ionization, than if either method was used by itself. NMR studies of the complexation of salicylic acid and acetylsalicylic acid with betaCD indicate that during the complex formation the benzene ring of the drug molecules goes into the cavity from the wider side of the betaCD molecule. These studies also show that in the acetylsalicylic acid-betaCD inclusion complex the benzene ring is located well inside the cavity and the acetyl group is outside the cavity. This complexation mechanism is also supported by degradation studies.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 23 条
[1]   INTERACTION OF NSA WITH CYCLODEXTRINS AND HYDROXYPROPYL CYCLODEXTRIN DERIVATIVES [J].
BACKENSFELD, T ;
MULLER, BW ;
KOLTER, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 74 (2-3) :85-93
[2]   EFFECT OF CYCLODEXTRIN DERIVATIVES ON INDOMETHACIN STABILITY IN AQUEOUS-SOLUTION [J].
BACKENSFELD, T ;
MULLER, BW ;
WIESE, M ;
SEYDEL, JK .
PHARMACEUTICAL RESEARCH, 1990, 7 (05) :484-490
[3]  
BETTINETTI GP, 1989, FARMACO, V44, P195
[4]  
DELGADO JN, 1991, WILSON GISVOLDS TXB, P877
[5]   BINDING MECHANISMS IN CYCLOHEXAAMYLOSE COMPLEXES [J].
GELB, RI ;
SCHWARTZ, LM ;
CARDELINO, B ;
FUHRMAN, HS ;
JOHNSON, RF ;
LAUFER, DA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1981, 103 (07) :1750-1757
[6]  
Haigh C, 1980, PROGR NMR SPECTROSCO, V13, P303
[7]  
JONE SRAY, 1979, PHYSICAL MECHANISTIC, P227
[8]   AGGREGATION OF AMPHOTERICIN-B IN THE PRESENCE OF GAMMA-CYCLODEXTRIN [J].
KAJTAR, M ;
VIKMON, M ;
MORLIN, E ;
SZEJTLI, J .
BIOPOLYMERS, 1989, 28 (09) :1585-1596
[9]   THE EFFECTS OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN ON THE SOLUBILITY AND STABILITY OF CHLORAMBUCIL AND MELPHALAN IN AQUEOUS-SOLUTION [J].
LOFTSSON, T ;
BJORNSDOTTIR, S ;
PALSDOTTIR, G ;
BODOR, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 57 (01) :63-72
[10]  
LOFTSSON T, 1992, ACTA PHARM NORDICA, V4, P329